AnandPathakMDPhD, MPH

Public Health & General Preventive Medicine

Medical Officer, FDA

Dr. Pathak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
10903 New Hampshire Blvd
Silver Spring, MD 20993
Phone+1 513-313-8620

Visionary thought leader in molecular diagnostics for precision oncology and cutting edge molecular diagnostics cancer screening.

University of Michigan School of Public HealthResidency, Public Health and General Preventive Medicine, 2010 - 2012
Jewish Hospital of CincinnatiResidency, Internal Medicine, 2008 - 2009
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2007 - 2008
University of Cincinnati College of MedicineClass of 2007

MI State Medical License 2012 - 2025
American Board of Preventive Medicine Public Health & General Preventive Medicine

PubMed

30 citations
Mosaic chromosome Y loss and testicular germ cell tumor risk.
Mitchell J. Machiela, Casey L. Dagnall, Anand Pathak, Jennifer T. Loud, Stephen J. Chanock
Journal of Human Genetics. 2017-03-09
33 citations
Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family
Anand Pathak, Katja Seipel, Alexander Pemov, Ramita Dewan, Christina Brown
Haematologica. 2016-07-01
15 citations
Rare inactivating PDE11A variants associated with testicular germ cell tumors
Anand Pathak, Douglas R. Stewart, Fabio R. Faucz, Paraskevi Xekouki, Sara Bass
Endocrine-Related Cancer. 2015-12-01

50% of Children with Cancer Are Left Undiagnosed and Untreated: StudyMarch 6th, 2019
Public Workshop - Next Generation Sequencing-Based Oncology Panels, February 25, 2016February 25th, 2016